Skip to main content
Publication date
2018 09 08
Authors
Ahmad, N Ahuja, SD Akkerman, OW Alffenaar, JWC Anderson, LF Baghaei, P Bang, D Barry, PM Bastos, ML Behera, D Benedetti, A Bisson, GP Boeree, MJ Bonnet, M Brode, SK Brust, JCM Cai, Y Caumes, E Cegielski, JP Centis, R Chan, PC Chan, ED Chang, KC Charles, M Cirule, A Dalcolmo, MP D'Ambrosio, L de Vries, G Dheda, K Esmail, A Flood, J Fox, GJ Frechet-Jachym, M Fregona, G Gayoso, R Gegia, M Gler, MT Gu, S Guglielmetti, L Holtz, TH Hughes, J Isaakidis, P Jarlsberg, L Kempker, RR Keshavjee, S Khan, FA Kipiani, M Koenig, SP Koh, WJ Kritski, A Kuksa, L Kvasnovsky, CL Kwak, N Lan, ZY Lange, C Laniado-Laborin, R Lee, M Leimane, V Leung, CC Leung, ECC Li, PZ Lowenthal, P Maciel, EL Marks, SM Mase, S Mbuagbaw, L Migliori, GB Milanov, V Miller, AC Mitnick, CD Modongo, C Mohr, E Monedero, I Nahid, P Ndjeka, N O'Donnell, MR Padayatchi, N Palmero, D Pape, JW Podewils, LJ Reynolds, I Riekstina, V Robert, J Rodriguez, M Seaworth, B Seung, KJ Schnippel, K Shim, TS Singla, R Smith, SE Sotgiu, G Sukhbaatar, G Tabarsi, P Tiberi, S Trajman, A Trieu, L Udwadia, ZF van der Werf, TS Veziris, N Viiklepp, P Vilbrun, SC Walsh, K Westenhouse, J Yew, WW Yim, JJ Zetola, NM Zignol, M Menzies, D
Group authors
Collaborative Grp Meta-Analysis In
Pubmed ID
30215381
Journal
Lancet (London, England)
Doctype
Article
KI Connection
Låg
Mesh SV
Amikacin Antituberkulosmedel Behandlingssvikt Diarylquinoliner Fluorokinoloner Kanamycin Kapreomycin Karbapenemer Klofazimin Kombinationsbehandling Levofloxacin Linezolid Lungtuberkulos Människa Tuberkulos, läkemedelsresistent Återfall
Mesh EN
Amikacin Antitubercular Agents Capreomycin Carbapenems Clofazimine Diarylquinolines Drug Therapy, Combination Fluoroquinolones Kanamycin Levofloxacin Linezolid Moxifloxacin Recurrence Treatment Failure Tuberculosis, Multidrug-Resistant Tuberculosis, Pulmonary
First date
2018-09-24T14:28:46.334Z